chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Customer stated he experienced symptoms of hallucinations, fever over 100 degrees, shaking chills beginning 6 hours after the injection.      He called this morning  (approx 24 hours later) stating his symptoms were beginning to subside, but still has a fever at or above 100 degrees.   I recommended he continue to take tylenol and consult his primary care doctor.
About 4 hours following DTAP administration patient developed 103 fever with "seizure-like" movements for 3 nights (per mom). Pt never evaluated by medical provider for episode. Arms and legs would "stiffen and twitch" at nighttime when fever was highest. Fever persisted for 3 days, but "seizure-like movements" only at nighttime.
COPD-like symptoms including weakness and shortness of breath began in early May after 2nd dose on 4/21/2021, lot 027B21A.
I had a breakthrough case of Covid-19 It started with chills with fever runny nose cough and congestion for 3 days I was prescribed Paxlovid on day 3.
30 mins after receiving MENACTRA #1 & HPV #1 mom states pt had behavioral changes, dizziness & "acted drunk" until about 9 pm the same day.
I had 3 days about 101 fever, nausea, sever headaches, flu. It started the next day around 8:00AM. Bad flu, It was hard for me to walk.  I was dizzy. I had fatigue for 5 days. I took Tylenol, Zofran  and I got better.
pt recv vax 21APR97 & looked pale;cold skin;pt was shaking;BP 100/80;pt was given 02;pt seen in ER:pt never lost consciousness, did not have bradycardia or low BP
I was at home night of 12/16 ex headache, chills upon checking temp 99.3. My arm was swollen and couldn't move my arm .I took Ibuprofen 400 mg and went to sleep. On 12/17 felt like flu symptoms and voice raspy sound and took 400 mg Ibuprofen. Then 12/18 today felt better and gaining voice back.
Within 24 hours post vax, pt developed an injection site reaction characterized by redness, warmth and swelling.
pain in injection area; bad headache; nauseous; hot flashes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 28Apr2021 18:30 (Lot number: EW0162) at the age of 27 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLELot Number: ER8734Anatomical site: Arm LeftAdministration time: 18:00), administration date: 07Apr2021, when the patient was 27 years old, for COVID-19 immunization, reaction(s): "Vaccination site pain". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 29Apr2021 10:15, outcome "unknown", described as "pain in injection area"; HEADACHE (non-serious) with onset 29Apr2021 10:15, outcome "unknown", described as "bad headache"; NAUSEA (non-serious) with onset 29Apr2021 10:15, outcome "unknown", described as "nauseous"; HOT FLUSH (non-serious) with onset 29Apr2021 10:15, outcome "unknown", described as "hot flashes".  No follow-up attempts are possible. No further information is expected.
3.5 cm x 7 cm area of painful, tender, warm erythema along lateral right upper arm onset this morning.
2.5 cm diameter area of induration, redness around injection site (L) ant. thigh.
On April 22, 2012 pt developed fevers, decreased appetite, temp to 101.9, red, splotchy rash. Seen by MD & dx'd with possible Fifths disease. Rash subsided by 4/29 but fevers persisted. On 4/29 admitted to PICU with lethargy, intubated and eventually diagnosed with ADEM, necrotizing form currently in vegetative state.
Bell's palsy - reactivate herpes simplex scars right eye; Bell's palsy - reactivate herpes simplex scars right eye; Bell's palsy - reactivate herpes simplex scars right eye; positive COVID-19 test; positive COVID-19 test; This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EL1284; Expiration date: 30Apr2021), via an unspecified route of administration in the right arm, on 23Jan2021 (at the age of 72-years-old) at a single dose for COVID-19 immunization. Medical history included high blood pressure (HBP) and COVID-19. The patient had no known allergies. Concomitant medications, taken within two weeks of vaccination, included unspecified medications. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on an unspecified date for COVID-19 immunization and influenza vaccine (FLU) on 05Jan2021 for immunization. The patient experienced positive COVID-19 test on 27Jan2021 and Bell's palsy - reactivate herpes simplex scars right eye on 01Feb2021. The patient underwent lab tests and procedures which included COVID-19 nasal swab: positive on 27Jan2021. Therapeutic measures were taken as a result of Bell's palsy - reactivate herpes simplex scars right eye, which included ganciclovir (ZIRGAN). The clinical outcome of positive COVID-19 test was unknown and of Bell's palsy - reactivate herpes simplex scars right eye was not recovered.
This spontaneous report was received from a pharmacist concerning a 61 year old male patient. The patient's medical history included a splenectomy on unspecified date (prior to receiving PNEUMOVAX). On 09-OCT-2014, the patient was vaccinated with PNEUMOVAX 23, 0.5 ml intramuscular route in the left arm, (lot # K007773; Exp. Date: 01-MAY-2015) (strength not provided). Concomitant therapies included influenza virus vaccine (manufacturer unknown) applied on the same day in the right arm. On 09-OCT-2014, the patient experienced pain and problems with range of motion in his left arm and shoulder after receiving PNEUMOVAX 23. The patient was having difficulty doing his job due to the pain and limited range of motion in his left shoulder. The patient weighted 210 pounds and 1 inch long needle was used administered about 2 inches from the top of the patient's shoulder. Patient sought medical attention through an office visit. Patient received treatment with lipoderm patches and ibuprofen. Labs diagnostics studies were not performed. At the time of the report, the outcome of the events was reported as not recovered. The causal relationship between the events and PNEUMOVAX 23 was unknown. Additional information has been requested.
Woke up fine around 6am. As I was moving around, I noticed at about 6:45am that my neck was getting stiff. Within 15-30 minutes my neck could barely move without pain. My head also noticeable was leaning to my right side. My upper back, should blade area became tight and I couldn't really use my arms without having pain in the area. I went home and laid down on a heating pad. I couldn't even flinch without pain in the area. As the afternoon went on, it got a little better. I took Ibuprofen which helped a little. The next day it was slightly better. Today is 4/29, almost a week later and it's still not 100%. My neck is stiff. The right side where my shoulder blade ends is in a lot of pain. I can't really lift anything.
This spontaneous report as received from a physician refers to a 17 year old female patient who on an unknown date, was vaccinated with first dose of RECOMBIVAX HB (Lot # and route not provided). On an unknown date, was vaccinated with second dose of RECOMBIVAX HB (Lot # and route not provided). On an unknown date, was vaccinated with third dose of RECOMBIVAX HB (Lot # and route not provided). No concomitant medications were reported. The nurse stated that on unspecified date, a patient who received three doses of RECOMBIVAX HB as an infant, has been determined to have negative antibody titers to hepatitis B. The patient did not receive any treatment for adverse event. The patient sought medical attention. The outcome of anti-hbs antibody negative was unknown. The relatedness adverse event was unknown for RECOMBIVAX HB. Additional information has been requested.
Site: Pain at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Lymph Node Swelling-Mild, Additional Details: patient called to question new pain at the injection site from receiving booster. patient reported "armpit pain" questioned if this was linked to swollen lymph nodes. this is only in left arm, patient was moving furniture today and possible aggrevation of arm from heavy lifting. patient stated he was taking apap to relieve pain.
This case was reported by a healthcare professional and described the occurrence of injection site redness in an unknown number of subjects of unspecified age and gender who were vaccinated with FLULAVAL (GlaxoSmithKline). In 2013 the subject received a dose of FLULAVAL (unknown details). In 2013, within months of vaccination with FLULAVAL, the subjects experienced injection site redness. The healthcare professional reported that "one patient had nausea, and many patients with redness at the site." The healthcare professional had previously reported nausea in 2 other cases (see cases A1043170A and A1043122A for details). At the time of reporting the outcome of the event was unspecified.
Pt showed for Covid Vasc #1, received the immunization in left deltoid.  minutes later, felt numbness, in arm, the a lump in the throat.  Denied SOB, or Dyspnea. Patient the stated weakness in the legs.  Assisted to the restroom, x 1.  no difficulty.  after 30 minutes and no relief from symptoms, patient was wheelchaired over to urgent care, and treated there.    Patient was able to leave urgent care on her own, with no problems Patient transferred to urgent care for evaluation.  Left from urgent care on her own
Light headedness began at 1pm Soreness in thighs began at 1:30pm Symptoms worsen by 2-2:30pm Body aches in back, neck, shoulder by 3:30pm Feeling nauseous, headache and  fatigued by 4:30pm 100 degree Fever by 5pm Body aches, headache and runny nose still persists by 7:30pm
I woke up at 3:30am (8 hours exactly after injection) and had severe chills.  Around 5am I began vomiting.  My entire body ached, my head hurt and I had a fever of 101.8.  Around 7am I was able to keep a piece of bread down and take Advil.   The fever started to go away but I was sweating the rest of the day.  Body aches continued all day, into the night and stopped the next day.
This spontaneous report as received from a certified medical assistant (CMA) refers to 9 patients of unknown age (no patient information provided). On an unknown date, temperature excursion to (Merck) VARIVAX of -7.9 degree centigrade for 79 hours. (Merck) VARIVAX was supported for use within 1 month. On an unknown date, 9 patients were vaccinated with a dose of (Merck) VARIVAX post excursion, lot # J014400, Expiration Date 13-NOV-2015, 0.5 ml, subcutaneously. No adverse effects reported. The patients did not seek medical attention. Additional information has been requested.
1500: Sx: Tingling legs, dry mouth, chills, dizziness; BP: 160/70, HR: 106, SpO2: 98%; Tx: Benadryl 50mg  1505: BP: 134/88, HR: 91, SpO2: 100%  1510: BP: 122/81, HR: 80; SpO2: 100%  1545: BP 135/84, HR: 80, SpO2: 100%
Patient passed out while waiting until his post injection required 15 minutes. Eyes rolled back and he vomiting all over himself. He was sweating perfusely. Called paramedics and they checked his blood pressure, and remained until he was stable. Patient left sometime later after he had rested .
Unspecific Adverse event; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Unspecific Adverse event) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Unspecific Adverse event). At the time of the report, ADVERSE EVENT (Unspecific Adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
This spontaneous report as received from a consumer of 77 year old with osteoporosis concerning herself. Patient had no other drug allergic reaction previously. On an unknown date of 2005, the patient was vaccinated with ZOSTAVAX (strength, dose unit, route, lot# and expiry date unknown) 1 time vaccine in her left arm to prevent shingles. Concomitant therapies included FOSAMAX. On an unknown date of 2005, the patient experienced pain and tenderness at the site of insertion after receiving the ZOSTAVAX vaccine. She was a participant in a clinical trial for ZOSTAVAX. Patient did not sought medical attention and no treatment was provided to the events. The outcome of pain and tenderness at the site of insertion was unknown. No other information was reported. Additional information has been requested.
Headache, Myalgia, CoughWheeze, NauseaVomiting, chills, sweating Narrative: referred to PCP/Urgent Care if sx persist. Empl. voiced understanding.
Initial report received from a healthcare professional on 08 April 2013. A 29-year-old female patient, whose medical history and concomitant medications were not reported, had received an intramuscular dose of ADACEL vaccine (Lot number: U4612AA, expiry date: 9/15, dose number was not reported) on left deltoid on 8 April 2013. The patient was pregnant at the time of vaccination. The patient's last menstrual period (LMP) date was on 5 September 2012 and estimated delivery date was reported as 12 June 2013. The patient's health during pregnancy and risk factors were not reported. As of 08 April 2013, the patient had not experienced any adverse event. Documents held by sender; none.
severe intermittent pain in the left arm from injection site deltoid; severe intermittent pain in the left arm from injection site deltoid to wrist; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 76-year-old female patient who received Herpes zoster (Shingrix) (batch number K9M5N, expiry date 7th November 2021) for prophylaxis.   On 28th August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced pain in arm and wrist pain. On an unknown date, the outcome of the pain in arm and wrist pain were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm and wrist pain to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in left deltoid. The patient experienced severe intermittent pain in the left arm from injection site deltoid to wrist for 6 months and till the time of reporting experiencing it. The reporter did not consent to follow up
Systemic: Nausea-Severe, Systemic: Vomiting-Medium, Additional Details: extreme tiredness from the day of vaccine which didnot go away even after 4 days and patient complains of not able to go to work
Diagnosis - Pericarditis  Severe chest, shoulder, and arm pain began early morning on 12/10. Visited Urgent Care later that morning, then sent to Cardiovascular Specialists. EKGs, blood work, and x-rays were all normal. 600mg of ibuprofen was prescribed, 3 times a day, for 7 days.  Pain reduced completely after second dose of ibuprofen, no pain since then. Monday,  12/13, went back to Cardiovascular Specialists for an ultrasound, results were normal.
Fever x 2 days, post vax. Rash on abdomen the next day, in a circle, not on any other part of body. Complains of arms and legs aching. Tylenol was given, post vax. On 4/5/00, rash almost gone and no fever but still had body aches. Rash did itch. Had DTAP #2 in January, 2000, and same thing occurred but mom didn't call.
pt recv vax & exp accelerated local rxn accompanied by 24-48 hr of systemic, self-limited illness;pt recovered from sx;
Nausea, headache, fatigue, low grade fever, dizziness/vertigo,
Flonase for nasal inflammation, Valsalva maneuver, Mini-epley maneuvers, Meclizine
This spontaneous report was received from a nurse via Pfizer, Inc. and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of M-M-R II, also reported as MMR (lot #, expiration date, dose and route of administration were not reported). Administered doses of vaccines experienced the highest temperature of 9.1 degrees Celsius and "out of range for five days, was at 8 degrees Celsius". It was not specified if a digital data logger was involved. There were no previous temperature excursions reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1703USA011907: US-009507513-1703USA011908: US-009507513-1703USA011909: US-009507513-1703USA011910.
Few days after the vaccine, the decedent complained of chest heaviness and not feeling well.  Found dead 10 days after the vaccine.
Pt came in pharmacy on 4/8/15 (after 7 dys of administration). Pain arm/shoulder, big red bruise on injection site, mild, itching. There was mild pain since 04/01/15.
injection site reaction Narrative:  per chart f/u on reported side side effects of the Pneumococcal  vaccine that he received last Wednesday (3/10/21). Patient reports some soreness (2/10) and redness on the injection site. Patient denied fever, vomiting,  shortness of breath
This case was reported by a pharmacist via call center representative and described the occurrence of general body pain in a 35-year-old female patient who received BOOSTRIX (batch number 9GE5D, expiry date 30th October 2017. Co-suspect products included FLUARIX QUADRILALENT (batch number 4Z27T, expiry date 25th June 2017. Concomitant products included PNEUMOVAX 23. On 23rd September 2016, the patient received BOOSTRIX .5 ml and FLUARIX QUADRIVALENT .5 ml. On 23rd September 2016, less than day after receiving BOOSTRIX and FLUARIX QUADRIVALENT and less than day after receiving BOOSTRIX and FLUARIX QUADRIVALENT, the patient experienced general body pain, fever, burning in eyes, headache and runny nose. On an unknown date, the outcome of the general body pain, fever, burning in eyes, headache and runny nose were not recovered/not resolved. The reporter considered the general body pain, fever, burning in eyes, headache and runny nose to be related to BOOSTRIX and FLUARIX QUADRIVALENT. Additional details were received as follows: This case was not previously reported to anyone. The age at vaccination was not reported. Caller reports patient experienced severe body aches after receiving vaccinations (BOOSTRIX: right deltoid, FLUARIX: left deltoid). The patient was part of family and all patients reports same events. This case was one of the 4 cases reported by the same reporter.
Day after 2nd vaccine, very tired, lethargic, slight headache.  Day 2  Woke up with painful swollen armpit on left side, by the evening...additional swollen and sore spot under collarbone, with a noticeable lump.  (Left side also.)
pt recvd vax & c/o sneezing; had sore throat & swollen glands in neck; to MD; dx of bronchitis;
Patient received a ZOSTAVAX injection on 10/24/17 and said that on 10/27/17 the area where she received the vaccine was red, swollen, and warm to the touch and contained a knot. She said that on 10/28/17 the area was much better, but that it was still slightly red. I told her to ice the area and to take an OTC pain reliever if needed. She will monitor the area for any worsening and call her doctor if needed.
Adverse Reactions of sore right arm for a day or two; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Adverse Reactions of sore right arm for a day or two) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014F21A) for COVID-19 prophylaxis.     The patient's past medical history included Sleep disturbance. Previously administered products included for Product used for unknown indication: Pfizer and Pfizer. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer. Concurrent medical conditions included Depression (since the age of 5). Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 06-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Dec-2021, the patient experienced VACCINATION SITE PAIN (Adverse Reactions of sore right arm for a day or two). In December 2021, VACCINATION SITE PAIN (Adverse Reactions of sore right arm for a day or two) had resolved.            The patient received Pfizer for her Primary Series. No treatment medications were reported.   This case was linked to MOD-2022-650930, MOD-2022-650962 (Patient Link).
Patient complained of limited movement in left arm 24 hours after injection.  She stated that she thinks the injector either "hit a tendon" or placed the injection off to the side of the deltoid.  She also stated that that evening after injection she used both arms to carry buckets.  This type of activity was not of the ordinary for her.   As of 3/2023 she feels as if she can still locatethe site of injection due to tenderness.
PT REPORTED VAGINAL "SPOTTING" TODAY. DENIES S/SX OF UTI. MENSTRUAL PERIOD DUE IN ABOUT A WEEK AND A HALF. NOT COMMON FOR PT. TO "SPOT". PT. GIVEN FEMININE NAPKIN
Report 200034925-1 describes a 48 year old female who did not seroconvert following receipt of three doses of hepatitis B vaccine.  Concurrent medical conditions included coronary artery disease, hypertension, and cancer of the cervix. Concurrent medications included an unspecified estrogen. The patient received injections of Engerix-B on 25 February 2000 (lot ENG3212A4), 25 March 2000 (lot ENG3350A4), and 25 August 2000 (lot ENG3212A4). Hepatitis b titers measured in November 2000 and on 04 January 2001 were negative. Hepatitis b titers measured on 11 january 2001 and 15 January 2001 were less than two. The reporter indicated that two patients were immunized with the same lots of Engerix-b on the same days. The other patient seroconverted.
fever, headache, nausea, extreme fatigue lasting 24 hours No treatment besides ibuprofen. Symptoms began aboue 20 hours after injection and gone 26 hours later
Women family members had reactions; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Women family members had reactions) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Women family members had reactions). At the time of the report, ADVERSE REACTION (Women family members had reactions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       61-year-old female patient is calling to ask a question and reported her side effects.  Case #MOD21-107498 Cross-Linked. (Reporter's Case) She inadvertently reported, "All women in my family had reactions to the vaccine vs. men were fine after vaccination."  No relevant concomitant medications were reported. No treatment information was provided.
Patient passed out immediately following injection of vaccine.  Her eyes rolled back and she was not able to speak.  The vaccinator got help immediately, and patient's husband was in the room.  She remained in a seated position with her husband holding her head up while standing behind her.  Her blood pressure dropped to 78/80, heart rate was 45 bpm.  She was unconscious for approximately one minute and 30 seconds.  911 was called immediately and she was transported to medical center. When I called the patient today, she did say that she was feeling better.  She mostly felt nauseous and dizzy following her vaccination.  She reports that her arm still feel itchy and that she has been taking Benedry